Skip to main content
رجوع
CHEOF logo

Cochlear Limited

جودة البيانات: 100%
ذروة بيع
CHEOF
OTC Healthcare Medical - Devices
KWD 116.81
▼ KWD 7.15 (-5.77%)
القيمة السوقية: 7.64B
مُدرج أيضًا باسم CHEOY OTC
نطاق اليوم
KWD 116.81 KWD 116.81
نطاق 52 أسبوعًا
KWD 116.81 KWD 207.71
حجم التداول
6,995
متوسط 50 يوم / 200 يوم
KWD 181.02 / KWD 185.43
الإغلاق السابق
KWD 123.96

تاريخ السعر

الاتجاهات المالية

مقارنة الأقران

مقابل وسيط قطاع Healthcare (627 نظير)

المقياس السهم وسيط القطاع
P/E 19.6 0.3
P/B 3.9 2.9
ROE % 20.5 3.7
Net Margin % 16.6 3.8
Rev Growth 5Y % 11.8 10.0
D/E 0.1 0.2

السعر المستهدف للمحللين

لا تتوفر تغطية محللين

تقديرات الأرباح

الفترة تقدير ربحية السهم تقدير الإيرادات المحللون
FY2030 KWD 11.529
KWD 10.932 – KWD 12.269
 2.5 B 1
FY2029 KWD 10.691
KWD 10.137 – KWD 11.377
 3.7 B 1
FY2028 KWD 8.504
KWD 8.064 – KWD 9.050
 3.2 B 1

النقاط الرئيسية

Revenue grew 11.84% annually over 5 years — strong growth
ROE of 20.52% indicates high profitability
Net margin of 16.60% shows strong profitability
Debt/Equity of 0.12 — conservative balance sheet
Generating 135.00M in free cash flow
Revenue growth is decelerating — 1Y growth trails 5Y average by 7.03%

النمو

Revenue Growth (5Y)
11.84%
Revenue (1Y)4.81%
Earnings (1Y)9.00%
FCF Growth (3Y)-28.83%

الجودة

Return on Equity
20.52%
ROIC13.93%
Net Margin16.60%
Op. Margin17.33%

الأمان

Debt / Equity
0.12
Current Ratio2.35
Interest Coverage36.92

التقييم

P/E Ratio
19.64
P/B Ratio3.92
EV/EBITDA18.71
Dividend Yield0.02%

All Fundamental Metrics

Growth
Revenue Growth (1Y) 4.81% Revenue Growth (3Y) 10.01%
Earnings Growth (1Y) 9.00% Earnings Growth (3Y) 13.74%
Revenue Growth (5Y) 11.84% Earnings Growth (5Y) 4.47%
Profitability
Revenue (TTM) 2.34B Net Income (TTM) 388.90M
ROE 20.52% ROA 13.77%
Gross Margin 73.74% Operating Margin 17.33%
Net Margin 16.60% Free Cash Flow (TTM) 135.00M
ROIC 13.93% FCF Growth (3Y) -28.83%
Safety
Debt / Equity 0.12 Current Ratio 2.35
Interest Coverage 36.92 Dividend Yield 0.02%
Valuation
P/E Ratio 19.64 P/B Ratio 3.92
P/S Ratio 3.26 PEG Ratio 5.17
EV/EBITDA 18.71 Dividend Yield 0.02%
Market Cap 7.64B Enterprise Value 7.60B

Income Statement

Annual, most recent first

Income statement data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 2.34B 2.24B 1.94B 1.65B 1.50B
Net Income 388.90M 356.80M 300.60M 289.10M 326.50M
EPS (Diluted) 5.93 5.43 4.56 4.40 4.93
Gross Profit 1.73B 1.67B 1.45B 1.24B 1.09B
Operating Income 406.10M 475.00M 389.50M 402.40M 370.20M

Balance Sheet

Annual, most recent first

Balance sheet data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 2.83B 2.75B 2.57B 2.47B 2.44B
Total Liabilities 874.70M 904.60M 819.90M 779.40M 736.50M
Shareholders' Equity 1.95B 1.84B 1.75B 1.69B 1.70B
Total Debt 235.70M 243.70M 201.80M 253.90M 264.30M
Cash & Equivalents 275.70M 513.60M 555.50M 629.30M 609.60M
Current Assets 1.42B 1.45B 1.36B 1.33B 1.23B
Current Liabilities 602.30M 631.50M 578.00M 527.60M 402.50M

درجات الاستراتيجيات

This stock passed the criteria for 1 strategy

Score = fit strength (0–100)
Rank = position among all matches
Value Value Investing (Warren Buffett)
#161 of 203
32

النشاط الأخير

دخل Value Investing (Warren Buffett)
Mar 24, 2026